Current Articles | Syndication

Thermo Fisher Scientific Introduces New Improved Universal Containers Sterilin 30mL Universals with quick start cap and improved leak-free performance NEWPORT, Wales (January 18, 2012) – Thermo Fisher Scientific, the world leader in serving science, today introduced a range of new, improved Thermo Scientific Sterilin 30mL Universal Containers with easier handling and improved leak-free performance.

E-learning package helps York Teaching Hospital meet CPA standards for Point of Care Testing Roche solution saves time and provides consistent, high standard of training which ultimately enhances patient safety As Point of Care (POC) diagnostic testing increases in healthcare facilities, the training of users to ensure that they are competent in using POCT equipment is becoming an ever growing challenge.This has been recognised in the Clinical Pathology Accreditation (CPA) standards for POC testing, which calls for POC testing facilities to demonstrate adequate training and recertification of operators. York Hospital has adopted the cobas® academy e-learning tool from Roche to help meet these requirements.

Highly specific Lp(a) assay from Randox available for chemistry analysers The Randox liquid ready to use Lipoprotein (a) assay provides a highly sensitive and specific method for the detection of Lp(a) in human serum and plasma.  The assay is based on an immunoturbidimetric method and is suitable for use on most chemistry analysers, the assay is not affected by Apo(a) size related bias like other commercially available methods.

Radiometer’s QA Portal helps Royal Hampshire meet EQA requirements The Royal Hampshire County Hospital (RHCH), Winchester, has six Radiometer blood gas analysers – including 810, 820, 825M and 835M systems – and relies on the Company’s QA Portal to help meet EQA requirements and simplify regulatory compliance. Colin Dickens, Manager of the Biochemistry Department at RHCH, explained: “All the blood gas analysers are connected using the RADIANCE system, which provides 24 hour monitoring to ensure our instruments are operating correctly and, as part of our quality assurance, we also use Radiometer’s QA Portal to monitor the alignment of the instruments.”

Point of care testing: Roche helps Stepping Hill Hospital to meet vital data management and audit requirements Stockport NHS Foundation Trust among first to achieve CPA accreditation for point of care testing (POCT) Roche cobas® IT1000 POCT Data Manager helps Stepping Hill Hospital to meet vital data management and audit requirements

Liquid ready to use Cystatin C assay from Randox provides a more sensitive marker of GFR compared to Creatinine The liquid ready to use Cystatin C assay from Randox provides a good indicator of Glomerular Filtration Rate (GRF). As a more sensitive maker of renal dysfunction, Cystatin C offers several advantages over traditional creatinine assays.

New molecular diagnostic test from Randox enables rapid, appropriate selection of Colorectal cancer patients for anti-EGFR therapy. Colorectal Cancer (CRC) is the third most common cancer worldwide1. Metastatic disease accounts for 40-50% of newly diagnosed patients and is associated with high morbidity 1,2. Despite recent therapeutic advances, the prognosis for metastatic CRC (mCRC) remains poor. Early diagnosis and assignment of the most appropriate therapy pathway is therefore crucial. The KRAS/BRAF/PIK3CA Array from Randox allows the clinician to select appropriate patients for anti-EGFR therapy, maximising drug efficacy and minimising adverse side effects to the patient.

St James Hospital, Dublin reaps time and workload benefits from a fully connected point of care solution Roche total solution ensures smooth delivery, management and monitoring of blood glucose and blood gas testing Point of care (POC) blood glucose and blood gas testing at St James Hospital, Dublin is managed centrally through the Roche cobas® IT 1000 point of care data management software. This has allowed significant time savings and more efficient workload management, and has helped the hospital to meet accreditation requirements for POC testing.

Thermo Fisher Scientific Provides Update on Important Microbiological Issues in Latest Edition of Oxoid Culture Journal Worldwide experts discuss the formation of multispecies biofilms and the impact of mycotoxin contamination in foods BASINGSTOKE, England (November 24, 2011) – Thermo Fisher Scientific, the world leader in serving science, today announced the availability of the latest edition of its microbiology journal, Culture. Volume 32, No. 2 focuses on two microbiological phenomena that have important impacts on human health and industry: the formation of multispecies biofilms and the production of mycotoxins in foods.

Novel In-Vitro Assays Developed for Mandatory EU-wide Allergen Testing Significant progress towards goal of replacing animal testing for key allergens 24 November 2011 – Proteome Sciences today announces that it has developed a number of novel in-vitro tests for chemical compounds and substances that induce allergies when they come into contact with the skin or the respiratory system. Testing for these allergens in products including chemicals, pharmaceuticals, cosmetics and detergents will become mandatory under EU legislation.

Paging - Page: 1 of 13 Previous Page | Next Page